The Role and Therapeutic Targeting of CCR5 in Breast Cancer is a research paper published in Cells (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01CA132115
NIH
Grant: R21CA235139
NIH
Grant: R43HL164131
NIH
Grant: #W81XWH1810605
National Institutes of Health
Grant: 1R01CA132115-01A1
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
National Institutes of Health
Grant: 1R21CA235139-01A1
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents
National Institutes of Health
Grant: 1R43HL164131-01A1
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity
FWCI
2.57
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals